And importantly, the known driver gene of AML, HOXA9, was verified as a downstream target of RBM5, suggesting a new regulatory axis in leukemogenesis described in the proposed model (Fig. 8). This evidence concerns the gene HOXA9 and acute myeloid leukemia.